A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A

Can Commun Dis Rep. 2008 Nov;34(11):1-6.
[Article in En, French]

Abstract

Recent studies show that multidrug-resistant Streptococcus pneumoniae serotype 19A continues to emerge as a cause of invasive pneumococcal disease after the introduction of Prevnar. We report a case of multidrug-resistant S. pneumoniae serotype 19A meningitis successfully treated with vancomycin and levofloxacin. This case reinforces the need for the empiric use of vancomycin in meningitis and the need for alternative treatments.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefuroxime / therapeutic use
  • Drug Resistance, Multiple, Bacterial
  • Drug Therapy, Combination
  • Humans
  • Infant
  • Levofloxacin
  • Meningitis, Pneumococcal / diagnosis
  • Meningitis, Pneumococcal / drug therapy*
  • Microbial Sensitivity Tests
  • Ofloxacin / therapeutic use
  • Streptococcus pneumoniae
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Levofloxacin
  • Vancomycin
  • Ofloxacin
  • Cefuroxime